Industry
Tumor BRAC Analysis CDx Lab Established in Europe
Myriad Genetics has announced the establishment of a Tumor BRACAnalysis CDx laboratory in Europe in which Myriad's next-generation Tumor BRACAnalysis CDx test will identify many more ovarian cancer patients who may benefit from treatment with PARP inhibitors, such as olaparib. More...04 Nov 2014
Ventana to Develop Companion Diagnostics for ImmunoGen Anticancer Agents
Ventana Medical Systems, member of the Roche Group, has announced a collaboration agreement with ImmunoGen to develop biomarker assays and a companion diagnostic immunohistochemistry test for one or more of ImmunoGen's product candidates. More...03 Nov 2014
ERBA Diagnostics Enters Brazilian Sector with Leading-Edge Clinical Testing Portfolio
ERBA Diagnostics has announced that an integrated portfolio of its latest in vitro diagnostics platforms and reagents are now being made available to hospitals, references labs, and physician clinics in Brazil. More...02 Nov 2014
BD Advances Entry into NGS with Acquisition of GenCell Biosystems
Leading medical technology company Becton, Dickinson and Company has acquired GenCell Biosystems, a privately-held biotech company that has developed proprietary technologies that address key biological analysis protocols —from library preparation of Next Generation Sequencing to genotyping for agricultural applications. More...26 Oct 2014
Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
New
Sperm Quality Analyis Kit
QwikCheck Beads Precision and Linearity Kit
New
Gold Member
Automatic Hematology Analyzer
DH-800 Series
In Other News
Emergency Approval of Ebola Test Suggests Opportunity for Test Makers
EKF and Mass. General Collaborate to Develop Blood Tests for Cancer Patients
Merck KGaA to Buy Sigma-Aldrich for USD 17 Billion
Initiative Launched to Make Genetic Profiles a Routine Part of Clinical Decisions
Funding Awarded to Develop Diagnostic Point-of-Care Device for Sickle Cell Disease
First European Company Obtains CE-IVD Marking for Next Generation Sequencing in Routine Testing
Physician Office IVD Sector Nears USD 2.5 Billion
Newly CE-Marked Automated Respiratory Disease Assay Now Available
Illumina Partners with Pharmaceutical Companies to Develop Companion Diagnostics
Companion Testing Sector Increased Significantly in 2013
New Partnership Designed to Automate Dystrophin Measurement
Most IVD Sector Companies Look Outside the EU and USA for Growth
Rheonix and Life Technologies Introduce Molecular Testing Platform
Social Diagnostics Start-Up to Provide Simple, Affordable Tests Worldwide
Leica Biosystems Acquires Kreatech Diagnostics
Ventana Paves the Way for High-Standard Companion Diagnostic Clinical Trials Services in China
German Court Finds in Favor of Puritan in Patent Infringement Case
Genomic Biomarkers Assess Treatment Prognosis in Blood Cancers
EKF Wins Distribution Contract and Regulatory Approval for Target Regions
Beckman Coulter Acquires Siemens Healthcare Diagnostics’ Clinical Microbiology Business
IDT Acquires SURVEYOR Nuclease Product Line from Transgenomic
Fewer Regulatory Barriers in Europe Benefit Companion Diagnostics Sector
Biocartis and Abbott Enter Exclusive Partnership to Develop Multiplex Companion Diagnostics
LabMedica Industry News channel reports on mergers and takeovers, on cooperative agreements and on trends in the IVD industry worldwide.